Items where authors include "Riley, K"

Export as [feed] Atom [feed] RSS
Number of items: 6.

Article

Pike, A, Muus, P, Munir, T et al. (8 more authors) (2020) COVID‐19 infection in patients on anti‐complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience. British Journal of Haematology, 191 (1). E1-E4. ISSN 0007-1048

Griffin, M, Hillmen, P orcid.org/0000-0001-5617-4403, Munir, T et al. (4 more authors) (2019) Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria. Haematologica, 104 (3). e94-e96. ISSN 0390-6078

Conference or Workshop Item

Newton, DJ, McKinley, CE, Ricardo, A et al. (8 more authors) (2017) Assessment of Eculizumab and C5 Levels in PNH Treatment: Molar Ratio of Eculizumab to C5 Level Effectively Predicts Ongoing Dosage Changes in a Cohort of 50 Patients Treated with Eculizumab. In: 59th ASH Annual Meeting Abstracts, 09-12 Dec 2017, Atlanta, GA, USA.

McKinley, CE orcid.org/0000-0003-4006-8846, Richards, SJ, Munir, T et al. (8 more authors) (2017) Extravascular Hemolysis Due to C3-Loading in Patients with PNH Treated with Eculizumab: Defining the Clinical Syndrome. In: 59th ASH Annual Meeting, 09-12 Dec 2017, Atlanta, GA, USA.

Proceedings Paper

Macrae, F, Bowman, P, Linton, E et al. (9 more authors) (2018) BSH18-PO-150: Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria. In: British Journal of Haematology. 58th Annual Scientific Meeting of the British Society for Haematology, 16-18 Apr 2018, Liverpool, UK. Wiley , p. 130.

Macrae, F, Bowman, P, Linton, E et al. (13 more authors) (2017) Fibrinogen and Clot Structure Is Affected By Eculizumab in Patients with Paroxysmal Nocturnal Haemoglobinuria. In: Blood. 59th Annual Meeting of the American-Society-of-Hematology, 09-12 Dec 2017, Atlanta, GA. American Society of Hematology , p. 462.

This list was generated on Sun Mar 24 15:12:58 2024 GMT.